A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury (Q38016216)

27 August 2017

A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury (English)

1 reference

27 August 2017

traumatic brain injury

0 references

1 reference

Kevin W McConeghy

1

1 reference

27 August 2017

Jimmi Hatton

series ordinal

2

1 reference

27 August 2017

Lindsey Hughes

series ordinal

3

1 reference

27 August 2017

Aaron M Cook

series ordinal

4

1 reference

27 August 2017

1 July 2012

1 reference

27 August 2017

1 reference

27 August 2017

26

1 reference

27 August 2017

613-636

1 reference

27 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.2165/11634020-000000000-00000

27 August 2017

0 references

cites work

Trends in hospitalization associated with traumatic brain injury

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11634020-000000000-00000

Zinc supplementation is associated with improved neurologic recovery rate and visceral protein levels of patients with severe closed head injury.

21 January 2018

1 reference

12 December 2020

Critical appraisal of neuroprotection trials in head injury: what have we learned?

1 reference

12 December 2020

Effect of posttraumatic hyperglycemia on contusion volume and neutrophil accumulation after moderate fluid-percussion brain injury in rats

1 reference

12 December 2020

Mild traumatic lesion of the right parietal cortex in the rat: characterisation of a conditioned freezing deficit and its reversal by dizocilpine.

1 reference

12 December 2020

Explosive blast neurotrauma

1 reference

12 December 2020

Cyclosporin pharmacokinetics in the elderly

1 reference

12 December 2020

Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial

1 reference

12 December 2020

Cerebral energy metabolism during transient hyperglycemia in patients with severe brain trauma.

1 reference

12 December 2020

Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial.

1 reference

12 December 2020

Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocrit

1 reference

12 December 2020

Evaluation of nimodipine in the treatment of severe diffuse head injury: a double-blind placebo-controlled trial.

1 reference

12 December 2020

Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline

1 reference

12 December 2020

Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study.

1 reference

12 December 2020

Thresholds for cerebral ischemia after severe head injury: relationship with late CT findings and outcome

1 reference

12 December 2020

Cyclosporine kinetics in renal transplantation

1 reference

12 December 2020

Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat.

1 reference

12 December 2020

Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury.

1 reference

12 December 2020

Posttreatment with intravenous basic fibroblast growth factor reduces histopathological damage following fluid-percussion brain injury in rats

1 reference

12 December 2020

Cytokines and metabolic dysfunction after severe head injury

1 reference

12 December 2020

Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations

1 reference

12 December 2020

Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improvesoOutcome after brain trauma

1 reference

12 December 2020

Brain hydroxyl radical generation in acute experimental head injury.

1 reference

12 December 2020

Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial

1 reference

12 December 2020

Free radical pathways in CNS injury

1 reference

12 December 2020

Treatment with magnesium improves reference memory but not working memory while reducing GFAP expression following traumatic brain injury.

1 reference

12 December 2020

The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats

1 reference

12 December 2020

Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury

1 reference

12 December 2020

Erythropoietin as a neuroprotective agent in traumatic brain injury Review

1 reference

12 December 2020

Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact

1 reference

12 December 2020

Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I (IGF-I).

1 reference

12 December 2020

Current aspects of pathophysiology and cell dysfunction after severe head injury

1 reference

12 December 2020

Protective effects of aptiganel HCl (Cerestat) following controlled cortical impact injury in the rat.

1 reference

12 December 2020

Stilbazulenyl nitrone, a novel azulenyl nitrone antioxidant: improved neurological deficit and reduced contusion size after traumatic brain injury in rats

1 reference

12 December 2020

A molecular basis for the efficacy of magnesium treatment following traumatic brain injury in rats

1 reference

12 December 2020

NNZ-2566, a glypromate analog, improves functional recovery and attenuates apoptosis and inflammation in a rat model of penetrating ballistic-type brain injury

1 reference

12 December 2020

The potential role of JAK2/STAT3 pathway on the anti-apoptotic effect of recombinant human erythropoietin (rhEPO) after experimental traumatic brain injury of rats.

1 reference

12 December 2020

Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats: 31P magnetic resonance spectroscopy and behavioral studies

1 reference

12 December 2020

Pharmacological treatment of traumatic brain injury: a review of agents in development

1 reference

12 December 2020

Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination

1 reference

12 December 2020

Sequential pharmacotherapy with magnesium chloride and basic fibroblast growth factor after fluid percussion brain injury results in less neuromotor efficacy than that achieved with magnesium alone.

1 reference

12 December 2020

A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.

1 reference

12 December 2020

Guidelines for the management of severe traumatic brain injury.

1 reference

12 December 2020

Effect of the modified Glasgow Coma Scale score criteria for mild traumatic brain injury on mortality prediction: comparing classic and modified Glasgow Coma Scale score model scores of 13

1 reference

12 December 2020

Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration.

1 reference

12 December 2020

Dosing and safety of cyclosporine in patients with severe brain injury

1 reference

12 December 2020

Subacute neural stem cell therapy for traumatic brain injury

1 reference

12 December 2020

Effect of noncompetitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury

1 reference

12 December 2020

Acute treatment with the 5-HT(1A) receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain trauma

1 reference

12 December 2020

mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors

1 reference

12 December 2020

Assessing quality of life after traumatic brain injury: examination of the short form 36 health survey.

1 reference

12 December 2020

The cerebral hemodynamic and metabolic effects of the noncompetitive NMDA antagonist CNS 1102 in humans with severe head injury

1 reference

12 December 2020

The influence of hyperglycemia on neurological outcome in patients with severe head injury

1 reference

12 December 2020

A randomized trial of nimodipine in severe head injury: HIT I. British/Finnish Co-operative Head Injury Trial Group.

1 reference

12 December 2020

Roles of NF-kappaB in central nervous system damage and repair

1 reference

12 December 2020

Magnesium and riboflavin combination therapy following cortical contusion injury in the rat.

1 reference

12 December 2020

Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF-κB pathway after traumatic brain injury in the rat.

1 reference

12 December 2020

Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors

1 reference

12 December 2020

Effects of posttraumatic carbamylated erythropoietin therapy on reducing lesion volume and hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome in rats following traumatic brain injury

1 reference

12 December 2020

Predicting 14-day mortality after severe traumatic brain injury: application of the IMPACT models in the brain trauma foundation TBI-trac® New York State database.

1 reference

12 December 2020

Hypotension, hypoxia, and head injury: frequency, duration, and consequences

1 reference

12 December 2020

Cerebral circulation after head injury. 1. Cerebral blood flow and its regulation after closed head injury with emphasis on clinical correlations.

1 reference

12 December 2020

Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: comparison of treatment with single and triple dose

1 reference

12 December 2020

The duality of the inflammatory response to traumatic brain injury

1 reference

12 December 2020

Importance of aquaporins in the physiopathology of brain edema

1 reference

12 December 2020

Protective effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin against traumatic brain injury-induced cognitive deficits and neuropathology in adult male rats

1 reference

12 December 2020

A trial of the effect of nimodipine on outcome after head injury

1 reference

12 December 2020

Role of calcium in central nervous system injuries

1 reference

12 December 2020

Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome

1 reference

12 December 2020

Characterization of cerebral hemodynamic phases following severe head trauma: hypoperfusion, hyperemia, and vasospasm

1 reference

12 December 2020

Metabolic acetate therapy for the treatment of traumatic brain injury.

1 reference

12 December 2020

Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review.

1 reference

12 December 2020

S-nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats

1 reference

12 December 2020

Neuroprotective effects of erythropoietin on acute metabolic and pathological changes in experimentally induced neurotrauma

1 reference

12 December 2020

Effects of nimodipine on the cerebrovascular hemodynamics in patients with severe head injuries.

1 reference

12 December 2020

Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators.

1 reference

12 December 2020

Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats

1 reference

12 December 2020

BAY 38-7271: a novel highly selective and highly potent cannabinoid receptor agonist for the treatment of traumatic brain injury.

1 reference

12 December 2020

Alterations in IGF-I, BDNF and NT-3 levels following experimental brain trauma and the effect of IGF-I administration.

1 reference

12 December 2020

Minocycline synergizes with N-acetylcysteine and improves cognition and memory following traumatic brain injury in rats

1 reference

12 December 2020

Experimental models of traumatic brain injury: do we really need to build a better mousetrap?

1 reference

12 December 2020

Preclinical efficacy testing in middle-aged rats: nicotinamide, a novel neuroprotectant, demonstrates diminished preclinical efficacy after controlled cortical impact

1 reference

12 December 2020

The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI.

1 reference

12 December 2020

Early cerebral blood volume after severe traumatic brain injury in patients with early cerebral ischemia.

1 reference

12 December 2020

Fluid thresholds and outcome from severe brain injury

1 reference

12 December 2020

Post-injury administration of BIBN 99, a selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats

1 reference

12 December 2020

Riluzole reduces brain swelling and contusion volume in rats following controlled cortical impact injury.

1 reference

12 December 2020

Kinetics of polymorphonuclear neutrophil infiltration after a traumatic brain injury in rat.

1 reference

12 December 2020

Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice.

1 reference

12 December 2020

Neurobehavioral protection by the neuronal calcium channel blocker ziconotide in a model of traumatic diffuse brain injury in rats

1 reference

12 December 2020

Post concussion syndrome

1 reference

12 December 2020

PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders.

1 reference

12 December 2020

Prediction of post-traumatic complaints after mild traumatic brain injury: early symptoms and biochemical markers

1 reference

12 December 2020

Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats

1 reference

12 December 2020

Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature

1 reference

12 December 2020

Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial.

1 reference

12 December 2020

Nitric oxide in traumatic brain injury

1 reference

12 December 2020

Potential roles for statins in critically ill patients

1 reference

12 December 2020

The role of the complement system in traumatic brain injury

1 reference

12 December 2020

Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial

1 reference

12 December 2020

A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury

1 reference

12 December 2020

Administration of riboflavin improves behavioral outcome and reduces edema formation and glial fibrillary acidic protein expression after traumatic brain injury.

1 reference

12 December 2020

Quality of Life after Brain Injury (QOLIBRI): scale validity and correlates of quality of life.

1 reference

12 December 2020

Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271

1 reference

12 December 2020

Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact

1 reference

12 December 2020

Considerations in fluids and electrolytes after traumatic brain injury

1 reference

12 December 2020

Grafted neural progenitors migrate and form neurons after experimental traumatic brain injury.

1 reference

12 December 2020

An open-label study of CP-101,606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage

1 reference

12 December 2020

Variation in chronic nicotinamide treatment after traumatic brain injury can alter components of functional recovery independent of histological damage

1 reference

12 December 2020

Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update

1 reference

12 December 2020

Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain.

1 reference

12 December 2020

A delayed and chronic treatment regimen with the 5-HT1A receptor agonist 8-OH-DPAT after cortical impact injury facilitates motor recovery and acquisition of spatial learning

1 reference

12 December 2020

Unique challenges in clinical trials in traumatic brain injury

1 reference

12 December 2020

A multicenter trial of the efficacy of nimodipine on outcome after severe head injury. The European Study Group on Nimodipine in Severe Head Injury

1 reference

12 December 2020

Transplantation of neural stem cells enhances expression of synaptic protein and promotes functional recovery in a rat model of traumatic brain injury

1 reference

12 December 2020

Pyridoxine administration improves behavioral and anatomical outcome after unilateral contusion injury in the rat.

1 reference

12 December 2020

Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial

1 reference

12 December 2020

Enoxaparin reduces brain edema, cerebral lesions, and improves motor and cognitive impairments induced by a traumatic brain injury in rats

1 reference

12 December 2020

Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in rats

1 reference

12 December 2020

Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window.

1 reference

12 December 2020

Alkoxyl radical-scavenging activity of edaravone in patients with traumatic brain injury.

1 reference

12 December 2020

NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats

1 reference

12 December 2020

Clinical impact of early hyperglycemia during acute phase of traumatic brain injury.

1 reference

12 December 2020

Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.

1 reference

12 December 2020

Cyclosporin A disposition following acute traumatic brain injury

1 reference

12 December 2020

Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats

1 reference

12 December 2020

The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury

1 reference

12 December 2020

Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use.

1 reference

12 December 2020

Delayed administration of basic fibroblast growth factor (bFGF) attenuates cognitive dysfunction following parasagittal fluid percussion brain injury in the rat.

1 reference

12 December 2020

NPS 1506, a moderate affinity uncompetitive NMDA receptor antagonist: preclinical summary and clinical experience.

1 reference

12 December 2020

Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making

1 reference

12 December 2020

Pharmacokinetic alterations after severe head injury. Clinical relevance

1 reference

12 December 2020

Common data elements for traumatic brain injury: recommendations from the biospecimens and biomarkers working group

1 reference

12 December 2020

Effects of the NMDA antagonist CP-98,113 on regional cerebral edema and cardiovascular, cognitive, and neurobehavioral function following experimental brain injury in the rat.

1 reference

12 December 2020

Evaluation of a combined therapeutic regimen of 8-OH-DPAT and environmental enrichment after experimental traumatic brain injury

1 reference

12 December 2020

Progesterone exerts neuroprotective effects after brain injury

1 reference

12 December 2020

A review of progress in understanding the pathophysiology and treatment of brain edema

1 reference

12 December 2020

Clinical practice. Concussion

1 reference

12 December 2020

Influence of PARP-1 polymorphisms in patients after traumatic brain injury

1 reference

12 December 2020

Blood-brain barrier breach following cortical contusion in the rat.

1 reference

12 December 2020

Neuroprotective effect of eliprodil: attenuation of a conditioned freezing deficit induced by traumatic injury of the right parietal cortex in the rat.

1 reference

12 December 2020

Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.

1 reference

12 December 2020

Drug resistance in brain diseases and the role of drug efflux transporters.

1 reference

12 December 2020

The treatment of traumatic brain injury with velcade

1 reference

12 December 2020

Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury.

1 reference

12 December 2020

Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats.

1 reference

12 December 2020

Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine.

1 reference

12 December 2020

Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats.

1 reference

12 December 2020

Pathophysiology of brain edema formation

1 reference

12 December 2020

Improvement in mitochondrial dysfunction as a new surrogate efficiency measure for preclinical trials: dose-response and time-window profiles for administration of the calcium channel blocker Ziconotide in experimental brain injury

1 reference

12 December 2020

Corticosteroids for acute traumatic brain injury

1 reference

12 December 2020

ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury

1 reference

12 December 2020

Molecular mechanisms in the pathogenesis of traumatic brain injury

1 reference

12 December 2020

N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain

1 reference

12 December 2020

Statistical approaches to the univariate prognostic analysis of the IMPACT database on traumatic brain injury.

1 reference

12 December 2020

CYCLOSPORINE A PHARMACOKINETICS IN RHEUMATOID ARTHRITIS PATIENTS AFTER 6 MONTHS OF METHOTREXATE THERAPY

1 reference

12 December 2020

Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?

1 reference

12 December 2020

Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury

1 reference

12 December 2020

Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial

1 reference

12 December 2020

Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies

1 reference

12 December 2020

Lactate accumulation following concussive brain injury: the role of ionic fluxes induced by excitatory amino acids.

1 reference

12 December 2020

Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injury

1 reference

12 December 2020

Nimodipine in traumatic subarachnoid haemorrhage: a re-analysis of the HIT I and HIT II trials

1 reference

12 December 2020

Cerebral blood flow and metabolism in comatose patients with acute head injury. Relationship to intracranial hypertension.

1 reference

12 December 2020

Erythropoietin can promote survival of cerebral cells by downregulating Bax gene after traumatic brain injury in rats.

1 reference

12 December 2020

Neuroprotection by erythropoietin administration after experimental traumatic brain injury

1 reference

12 December 2020

Intraventricular infusion of the neurotrophic protein S100B improves cognitive recovery after fluid percussion injury in the rat.

1 reference

12 December 2020

Clinical trials in head injury

1 reference

12 December 2020

Surveillance for traumatic brain injury-related deaths--United States, 1997-2007.

1 reference

12 December 2020

Lazaroid U-74389G attenuates edema in rat brain subjected to post-ischemic reperfusion injury

1 reference

12 December 2020

Antioxidant therapies for traumatic brain injury

1 reference

12 December 2020

Posttraumatic vasospasm: the epidemiology, severity, and time course of an underestimated phenomenon: a prospective study performed in 299 patients

1 reference

12 December 2020

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial

1 reference

12 December 2020

Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury

1 reference

12 December 2020

Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival

1 reference

12 December 2020

Riluzole attenuates cortical lesion size, but not hippocampal neuronal loss, following traumatic brain injury in the rat.

1 reference

12 December 2020

Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats.

1 reference

12 December 2020

Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial

1 reference

12 December 2020

Therapeutic evaluation of etanercept in a model of traumatic brain injury

1 reference

12 December 2020

Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists.

1 reference

12 December 2020

Cell death mechanisms following traumatic brain injury

1 reference

12 December 2020

Pathophysiology of traumatic brain injury

1 reference

12 December 2020

Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury

1 reference

12 December 2020

The neurobehavioral benefit conferred by a single systemic administration of 8-OH-DPAT after brain trauma is confined to a narrow therapeutic window

1 reference

12 December 2020

The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia

1 reference

12 December 2020

Sustained delivery of nicotinamide limits cortical injury and improves functional recovery following traumatic brain injury

1 reference

12 December 2020

Effect of recombinant human growth hormone and insulin-like growth factor-1 administration on IGF-1 and IGF-binding protein-3 levels in brain injury

1 reference

12 December 2020

Nicotinamide treatment induces behavioral recovery when administered up to 4 hours following cortical contusion injury in the rat

1 reference

12 December 2020

Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care

1 reference

12 December 2020

A controlled cortical impact model of traumatic brain injury in the rat

1 reference

12 December 2020

Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury

1 reference

12 December 2020

Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).

1 reference

12 December 2020

Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome

1 reference

12 December 2020

Molecular and cellular mechanisms in the pathophysiology of severe head injury

1 reference

12 December 2020

Insulin-like growth factor-1 (IGF-1) improves both neurological motor and cognitive outcome following experimental brain injury.

1 reference

12 December 2020

Traumatic Brain Injury in the United States: A Public Health Perspective

1 reference

12 December 2020

Effect of acute phase response on phenytoin metabolism in neurotrauma patients

1 reference

12 December 2020

Insulin-like signaling, nutrient homeostasis, and life span

1 reference

12 December 2020

Effect of rosuvastatin on amnesia and disorientation after traumatic brain injury (NCT003229758).

1 reference

12 December 2020

The genomic profile of the cerebral cortex after closed head injury in mice: effects of minocycline

1 reference

12 December 2020

Trends in head injury outcome from 1989 to 2003 and the effect of neurosurgical care: an observational study.

1 reference

12 December 2020

Traumatic Cerebral Vascular Injury: The Effects of Concussive Brain Injury on the Cerebral Vasculature

1 reference

12 December 2020

Cerebral autoregulation following head injury.

1 reference

12 December 2020

Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study

1 reference

12 December 2020

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

1 reference

12 December 2020

A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury

1 reference

12 December 2020

Calcium channel blockers for acute traumatic brain injury

1 reference

12 December 2020

Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group

1 reference

12 December 2020

Sprouting of corticospinal tract axons from the contralateral hemisphere into the denervated side of the spinal cord is associated with functional recovery in adult rat after traumatic brain injury and erythropoietin treatment

1 reference

12 December 2020

Lazaroid attenuates edema by stabilizing ATPase in the traumatized rat brain.

1 reference

12 December 2020

The effects of a ketogenic diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult rat.

1 reference

12 December 2020

Assessment of cerebrovascular autoregulation in head-injured patients: a validation study

1 reference

12 December 2020

10.2165/11634020-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference